The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary phase 1 results of a MICA/B-targeted CAR T cell designed to overcome solid tumor escape mechanisms and avoid the requirement for conditioning chemotherapy.
 
Manish Patel
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); Merck KGaA (Inst)
 
Ecaterina Dumbrava
Consulting or Advisory Role - Bolt Biotherapeutics; Fate Therapeutics; Mersana; PMV Pharma; Summit Therapeutics
Speakers' Bureau - PMV Pharma
Research Funding - A2A Pharmaceuticals (Inst); Aileron Therapeutics (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Bellicum Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Bolt Biotherapeutics (Inst); Compugen (Inst); Dragonfly Therapeutics (Inst); Fate Therapeutics (Inst); Genentech (Inst); Immunocore (Inst); Immunomedics/Gilead (Inst); Mereo BioPharma 5 (Inst); Mersana (Inst); ModeX Therapeutics (Inst); Pfizer (Inst); PMV Pharma (Inst); Poseida (Inst); Rain Therapeutics (Inst); Sanofi (Inst); Sotio (Inst); Triumvira Immunologics, Inc (Inst); Volastra Therapeutics (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Rain Oncology; Triumvira Immunologics, Inc
 
Heinz-Josef Lenz
Honoraria - Abbvie; Adagene; Bayer; Boehringer Ingelheim; Fulgent Genetics; Janssen Oncology; Jazz Pharmaceuticals; Merck Serono; Merus; Roche
Consulting or Advisory Role - 3T BioSciences; Abbvie; Adagene; Bayer; BMS; Fulgent Genetics; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; BMS; Merck Serono
 
Kyla Omilusik
Employment - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
 
Samad Ibitokou
Employment - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
 
Cara Bickers
Employment - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
 
Olena Kolesnichenko
Employment - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
 
Beatrice Ferguson
Employment - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
 
Seth Peng
Employment - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
 
Deepa Patel
Employment - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
 
Martin Hosking
Employment - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
 
Bahram Valamehr
Employment - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
 
Rebecca Elstrom
Stock and Other Ownership Interests - BeiGene; Fate Therapeutics
Consulting or Advisory Role - Fate Therapeutics
 
Lilly Wong
Employment - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
 
Ida Micaily
No Relationships to Disclose